Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19-Reference-Cited by-同舟云学术

Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19

Published:2020-06-08 Issue:9 Volume:75 Page:2708-2710
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Peiffer-Smadja Nathan¹²,Lescure François-Xavier¹³,Sallard Erwan⁴,Ravaud Philippe⁵,Vegreville Bruno⁶,Zeitoun Jean-David⁵⁶

Affiliation:

1. Université de Paris, IAME, INSERM, F-75018 Paris, France

2. National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK

3. Department of Infectious and Tropical Diseases, Assistance Publique—Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018 Paris, France

4. École normale supérieure de Paris, 45 rue d’Ulm, 75005 Paris, France

5. U1153, Epidemiology and Biostatistics Sorbonne, Paris Cite Research Center (CRESS), Methods of therapeutic evaluation of chronic diseases team (METHODS), INSERM, Université Paris Descartes, Paris, Île-de-France, France

6. Inato, Paris, France

Funder

Inato

internal funding

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/75/9/2708/33665183/dkaa223.pdf

Reference5 articles.

1. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review;Sanders;JAMA,2020